Novo Nordisk

Teva Is Still Healthier Than Its Big Pharma Peers
Seeking Alpha
Thu, 11/15/12 - 10:47 am
Teva
AstraZeneca
Bristol-Myers Squibb
GSK
JNJ
Merck
Novo Nordisk
Novartis
Pfizer
Sanofi
Degludec And Liraglutide: 2 Drivers Of Novo Nordisk's Growth
Seeking Alpha
Tue, 11/13/12 - 12:11 pm
diabetes
degludec
liraglutide
Novo Nordisk
Victoza
This Week in Biotech: Part 1
Motley Fool
Sun, 11/11/12 - 09:17 am
Novartis
Novo Nordisk
Corcept Therapeutics
Biomarin
Sequenom
Novo Aims for Tresiba U.S. Approval in First Half of 2013
Bloomberg
Fri, 11/9/12 - 11:07 am
Novo Nordisk
Tresiba
diabetes
degludec
insulin
FDA panel recommends approval of Novo degludec insulin
Reuters
Thu, 11/8/12 - 09:52 pm
FDA
advisory panels
Novo Nordisk
degludec
insulin
Why Investors Are Voting Against Novo Nordisk
Motley Fool
Wed, 11/7/12 - 11:55 am
Novo Nordisk
FDA
advisory panels
Tresiba
insulin
5 Companies Dominating Diabetes
Motley Fool
Tue, 11/6/12 - 04:21 pm
diabetes
AstraZeneca
Bristol-Myers Squibb
Sanofi
Novo Nordisk
MannKind
5 Things to Watch This Week in the Health-Care Sector
Motley Fool
Tue, 11/6/12 - 12:28 pm
Novartis
Signifor
Novo Nordisk
Tresiba
Ryzodeg
HCA Holdings
FDA staff highlight heart risk with Novo insulin
Reuters
Tue, 11/6/12 - 10:12 am
Novo Nordisk
FDA
insulin
degludec
Novo hikes forecast on 62% jump in Victoza sales
Fierce Pharma
Wed, 10/31/12 - 11:14 am
Novo Nordisk
guidance
2012's Best Pharmaceutical Stock
Motley Fool
Sun, 10/28/12 - 11:50 am
Novo Nordisk
Novo Nordisk says FDA disclosed focus of upcoming panel meeting
The Fly on the Wall
Fri, 10/26/12 - 10:32 am
FDA
advisory panels
Novo Nordisk
diabetes
degludec
FDA panel to weigh heart safety of Novo's new insulin
Reuters
Thu, 10/25/12 - 05:33 pm
advisory panels
FDA
Novo Nordisk
insulin
diabetes
degludec
Novo Nordisk: Encouraging Pipeline News
Seeking Alpha
Tue, 10/23/12 - 09:13 am
Novo Nordisk
Tresiba
Ryzodeg
diabetes
Novo's long-acting insulin degludec takes big step to megamarket status
Fierce Biotech
Fri, 10/19/12 - 12:20 pm
degludec
Novo Nordisk
diabetes
insulin
Europe
Tresiba
Novo Nordisk Is Positioned To Profit Off Of Obesity Epidemic But Price May Be Rich
Seeking Alpha
Tue, 10/9/12 - 09:55 am
obesity
Novo Nordisk
Merck
Bristol-Myers Squibb
diabetes
Sanofi
Novo to Hire 1,000 People in 2 Years in Emerging Markets
Bloomberg Businessweek
Fri, 10/5/12 - 12:23 pm
emerging markets
diabetes
Novo Nordisk
Novo Says It’s Likely to Benefit From Bristol-Amylin Tie-Up
Bloomberg
Fri, 10/5/12 - 11:25 am
Bristol-Myers Squibb
Novo Nordisk
Amylin
diabetes
NVO's Tresiba Approved in Japan
Yahoo/Zacks
Thu, 10/4/12 - 10:39 am
Novo Nordisk
Tresiba
Japan
diabetes
Bristol-Myers Squibb - Between Patent Deadlines And Revenue Shifts
Seeking Alpha
Wed, 10/3/12 - 10:50 am
patents
Bristol-Myers Squibb
Amylin
AstraZeneca
Novo Nordisk
Eli Lilly
Merck

Pages